- This event has passed.
2026 BioNJ Manufacturing Summit
September 29 @ 9:00 am – 4:30 pm
Manufacturing the Future of Biopharma:
Driving Innovation, Resilience & Patient Impact
Tuesday, September 29, 2026 | 9:00 am – 4:30 pm
Catalent, 104 Campus Dr, Princeton, NJ 08540
Thank you for the tremendous interest in BioNJ’s Manufacturing Summit. At this time, the event has reached capacity.
BioNJ’s Manufacturing Summit brings together industry thought leaders to explore the trends, challenges and opportunities shaping the future of biopharmaceutical manufacturing. Gain valuable insights on topics, including the future of small and large molecule manufacturing, supply chain resilience, the evolving regulatory landscape and New Jersey’s continued investment and growth in manufacturing — plus much more. Explore the full agenda below.
As a special highlight, attendees will also enjoy a guided tour of Catalent’s state-of-the-art manufacturing facility — offering a firsthand look at innovation in action.
Speakers
David Basile
Vice President
Technical Operations
Hovione
Matthew Breton
Executive Director
Process Development &
Manufacturing
Tr1X Bio
John Coelho, M.D.
Senior Advisor,
Life Sciences
NJEDA
Anthony DeBiase
Director, Digital Process
Development & Clinical Manufacturing
Continua Process Systems
George Eastwood
Executive Director
Emily Whitehead Foundation
Christine Harman, Ph.D.
Lead Consumer Safety Officer
Division of Manufacturing &
Product Quality, Office of Compliance & Biologics Quality, Center of Biologics Evaluation & Research (CBER)
Food & Drug Administration (FDA)
Debbie Hart
President & CEO
BioNJ
Peter Keller
CEO
BlueWhale Bio
Barbara Lavery
Chief Program Officer
Alliance for Cancer
Gene Therapy
Melanie Mansbach
General Manager
Cell Therapy
Catalent
Lance Marquardt
Director, Manufacturing Operations
ProBio
Michael Maurer
General Manager
Vice President U.S. Manufacturing
BeOne Medicines
Miguel Montano
Enterprise Data
Solutions Architect
Catalent
Michelle Moody
Director, Upstream
Process Development
Thermo Fisher Scientific
Viet Nguyen
Global Chief Operating Officer
Kashiv Biosciences
Himanshu Patel
Executive Director
Small Molecule Manufacturing Science
and Technology
Bristol Myers Squibb
Mariel Rezende
Associate Partner
McKinsey & Company
Jennifer Spalding, JD
Chief Commercial Officer
General Counsel
Corporate Secretary
Civica Rx
Sanjay Srivasta, Ph.D.
Managing Director
Accenture
Norm Stoffregen
Senior Vice President
& Site Head
Enzene Biosciences
Dan Strange
Chief Technology Officer
Cellular Origins
LeAnn Timble
Director, Emerging
Property Risk Control
Aon
John Tomtishen
Global Head, Cell Therapy
Field Application Scientists &
Strategic Alliances
Catalent
Bradley Watts
Patient Advocate
CAR-T Recipient
